151 related articles for article (PubMed ID: 25676572)
1. [Workshop - economic governance mechanisms : for Hematology and Oncology].
Strech D; Deh U; Schmitz S; Gürkan I; Ostermann H; Krause SW
Oncol Res Treat; 2015; 38 Suppl 1():3-22. PubMed ID: 25676572
[No Abstract] [Full Text] [Related]
2. [View].
Freund M; Lüftner D; Wilhelm M
Oncol Res Treat; 2015; 38 Suppl 1():23. PubMed ID: 25676573
[No Abstract] [Full Text] [Related]
3. [Forward].
Freund M; Lüftner D; Wilhelm M
Oncol Res Treat; 2015; 38 Suppl 1():1. PubMed ID: 25676571
[No Abstract] [Full Text] [Related]
4. [Rationalization, rationing, prioritization: terminology and ethical approaches to the allocation of limited resources in hematology/oncology].
Winkler E
Onkologie; 2011; 34 Suppl 1():2-5. PubMed ID: 21389761
[TBL] [Abstract][Full Text] [Related]
5. [Economy and medicine in haematology and oncology].
Krych M; Ostermann H
Dtsch Med Wochenschr; 2008 Oct; 133(41):2115-8. PubMed ID: 18985566
[No Abstract] [Full Text] [Related]
6. Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.
Dalley C; Basarir H; Wright JG; Fernando M; Pearson D; Ward SE; Thokula P; Krishnankutty A; Wilson G; Dalton A; Talley P; Barnett D; Hughes D; Porter NR; Reilly JT; Snowden JA
J Clin Pathol; 2015 Apr; 68(4):292-300. PubMed ID: 25631214
[TBL] [Abstract][Full Text] [Related]
7. The unit costs of inpatient hospital days, outpatient visits, and daycare treatments in the fields of oncology and hematology.
Tan SS; Van Gils CW; Franken MG; Hakkaart-van Roijen L; Uyl-de Groot CA
Value Health; 2010; 13(6):712-9. PubMed ID: 20561330
[TBL] [Abstract][Full Text] [Related]
8. Building a National Framework for Adolescent and Young Adult Hematology and Oncology and Transition from Pediatric to Adult Care: Report of the Inaugural Meeting of the "AjET" Working Group of the German Society for Pediatric Oncology and Hematology.
Escherich G; Bielack S; Maier S; Braungart R; Brümmendorf TH; Freund M; Grosse R; Hoferer A; Kampschulte R; Koch B; Lauten M; Milani V; Ross H; Schilling F; Wöhrle D; Cario H; Dirksen U
J Adolesc Young Adult Oncol; 2017 Jun; 6(2):194-199. PubMed ID: 27983882
[TBL] [Abstract][Full Text] [Related]
9. Affordable oncologic care: a challenging goal.
Barton MK
CA Cancer J Clin; 2014; 64(2):75-8. PubMed ID: 24420975
[No Abstract] [Full Text] [Related]
10. [Diagnosis-related groups as an instrument to develop suitable case-based lump sums in hematology and oncology].
Thalheimer M
Onkologie; 2011; 34 Suppl 1():11-5. PubMed ID: 21389763
[TBL] [Abstract][Full Text] [Related]
11. Provider Perspective on the Payer Perspective: What's in It for Me?
Stella PJ; Harrison KA
J Oncol Pract; 2015 May; 11(3):182-4. PubMed ID: 25804990
[No Abstract] [Full Text] [Related]
12. [Ethics and economics in oncology].
Winkler E; Schildmann J
Onkologie; 2011; 34 Suppl 1():1. PubMed ID: 21389760
[No Abstract] [Full Text] [Related]
13. WHA passes resolution on cancer prevention and control.
Burki TK
Lancet Oncol; 2017 Jul; 18(7):858. PubMed ID: 28602774
[No Abstract] [Full Text] [Related]
14. Purchasing oncology services. Kerr L. White Institute/American Cancer Society Task Force on Purchasing Oncology Services.
Cangialose CB; Blair AE; Borchardt JS; Ades TB; Bennett CL; Dickersin K; Gesme DH; Henderson IC; McGinnis LS; Mooney K; Mortenson LE; Sperduto P; Winkenwerder W; Ballard DJ
Cancer; 2000 Jun; 88(12):2876-86. PubMed ID: 10870075
[TBL] [Abstract][Full Text] [Related]
15. The role of hematologists in a changing United States health care system.
Wallace PJ; Connell NT; Abkowitz JL
Blood; 2015 Apr; 125(16):2467-70. PubMed ID: 25746327
[TBL] [Abstract][Full Text] [Related]
16. Developing a marketing action plan.
Lawson G; Washington G
Adm Radiol; 1993 Apr; 12(4):59-61, 63-4. PubMed ID: 10126365
[No Abstract] [Full Text] [Related]
17. A marketing planning analysis for a dedicated oncology and hematology inpatient service unit.
Fontaine SJ; Swartz BW
J Health Care Mark; 1989 Jun; 9(2):58-62. PubMed ID: 10303622
[No Abstract] [Full Text] [Related]
18. [Interest in and limitations of economic assessment applied to the evaluation of medical strategies: examples in oncological hematology].
Moatti JP
Therapie; 2001; 56(2):135-8. PubMed ID: 11471364
[TBL] [Abstract][Full Text] [Related]
19. Canada develops models of teleoncology.
Palkhivala A
J Natl Cancer Inst; 2011 Nov; 103(21):1566-8. PubMed ID: 22010180
[No Abstract] [Full Text] [Related]
20. [Rationing in German health care with particular consideration of oncology: view points of German stakeholders--a qualitative interview study].
Lange J; Gönner C; Vollmann J; Rauprich O
Gesundheitswesen; 2015 Jan; 77(1):8-15. PubMed ID: 24696371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
